» Articles » PMID: 37513855

Pharmacokinetics of Curcumin Delivered by Nanoparticles and the Relationship with Antitumor Efficacy: A Systematic Review

Overview
Publisher MDPI
Specialty Chemistry
Date 2023 Jul 29
PMID 37513855
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumin is a polyphenolic compound, derived from Curcuma longa, and it has several pharmacological effects such as antioxidant, anti-inflammatory, and antitumor. Although it is a pleiotropic molecule, curcumin's free form, which is lipophilic, has low bioavailability and is rapidly metabolized, limiting its clinical use. With the advances in techniques for loading curcumin into nanostructures, it is possible to improve its bioavailability and extend its applications. In this review, we gather evidence about the comparison of the pharmacokinetics (biodistribution and bioavailability) between free curcumin (Cur) and nanostructured curcumin (Cur-NPs) and their respective relationships with antitumor efficacy. The search was performed in the following databases: Cochrane, LILACS, Embase, MEDLINE/Pubmed, Clinical Trials, BSV regional portal, ScienceDirect, Scopus, and Web of Science. The selected studies were based on studies that used High-Performance Liquid Chromatography (HPLC) as the pharmacokinetics evaluation method. Of the 345 studies initially pooled, 11 met the inclusion criteria and all included studies classified as high quality. In this search, a variety of nanoparticles used to deliver curcumin (polymeric, copolymeric, nanocrystals, nanovesicles, and nanosuspension) were found. Most Cur-NPs presented negative Zeta potential ranging from -25 mV to 12.7 mV, polydispersion index (PDI) ranging from 0.06 to 0.283, and hydrodynamic diameter ranging from 30.47 to 550.1 nm. Selected studies adopted mainly oral and intravenous administrations. In the pharmacokinetics analysis, samples of plasma, liver, tumor, lung, brain, kidney, and spleen were evaluated. The administration of curcumin, in nanoparticle systems, resulted in a higher level of curcumin in tumors compared to free curcumin, leading to an improved antitumor effect. Thus, the use of nanoparticles can be a promising alternative for curcumin delivery since this improves its bioavailability.

Citing Articles

Role of PCBP2 in regulating nanovesicles loaded with curcumin to mitigate neuroferroptosis in neural damage caused by heat stroke.

Guo F, Wu Y, Wang G, Liu J J Nanobiotechnology. 2024; 22(1):800.

PMID: 39731111 PMC: 11681752. DOI: 10.1186/s12951-024-02889-4.


Curcumin Administration Routes in Breast Cancer Treatment.

Mayo B, Penroz S, Torres K, Simon L Int J Mol Sci. 2024; 25(21).

PMID: 39519045 PMC: 11546575. DOI: 10.3390/ijms252111492.


The Immunomodulatory Function of Assembled Composite Nanopolypeptide Containing Bursal-Derived BP7 (CNPB7) in Promoting the Mucosal Immune Response within Poultry Immunization.

Guo X, Hu J, Yin G, Cai Y, Gao Z, Liu Y Vaccines (Basel). 2024; 12(8).

PMID: 39203960 PMC: 11360326. DOI: 10.3390/vaccines12080834.


The Role of Curcumin in Oral Health and Diseases: A Systematic Review.

Inchingolo F, Inchingolo A, Latini G, Trilli I, Ferrante L, Nardelli P Antioxidants (Basel). 2024; 13(6).

PMID: 38929099 PMC: 11200638. DOI: 10.3390/antiox13060660.


Curcumin Nanoparticles-related Non-invasive Tumor Therapy, and Cardiotoxicity Relieve.

Cheng Y, Xu Q, Yu M, Dang C, Deng L, Chen H Curr Med Chem. 2024; 32(3):447-467.

PMID: 38918994 PMC: 11826934. DOI: 10.2174/0109298673305616240610153554.


References
1.
Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M . Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer. 2020; 20(1):791. PMC: 7446227. DOI: 10.1186/s12885-020-07256-8. View

2.
Aqil F, Munagala R, Jeyabalan J, Agrawal A, Gupta R . Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin. AAPS J. 2017; 19(6):1691-1702. DOI: 10.1208/s12248-017-0154-9. View

3.
Sharifi-Rad J, El Rayess Y, Abi Rizk A, Sadaka C, Zgheib R, Zam W . Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Front Pharmacol. 2020; 11:01021. PMC: 7522354. DOI: 10.3389/fphar.2020.01021. View

4.
Guo F, Fu Q, Jin C, Ji X, Yan Q, Yang Q . Dual functional matrix metalloproteinase-responsive curcumin-loaded nanoparticles for tumor-targeted treatment. Drug Deliv. 2019; 26(1):1027-1038. PMC: 6844435. DOI: 10.1080/10717544.2019.1676843. View

5.
Farani M, Azarian M, Hossein H, Abdolvahabi Z, Abgarmi Z, Moradi A . Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer. ACS Appl Bio Mater. 2022; 5(3):1305-1318. PMC: 8941513. DOI: 10.1021/acsabm.1c01311. View